166 related articles for article (PubMed ID: 35794782)
61. Myricetin ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β signaling via targeting HSP90β.
Li X; Yu H; Liang L; Bi Z; Wang Y; Gao S; Wang M; Li H; Miao Y; Deng R; Ma L; Luan J; Li S; Liu M; Lin J; Zhou H; Yang C
Biochem Pharmacol; 2020 Aug; 178():114097. PubMed ID: 32535102
[TBL] [Abstract][Full Text] [Related]
62. Preventive effects of Ecliptae Herba extract and its component, ecliptasaponin A, on bleomycin-induced pulmonary fibrosis in mice.
You XY; Xue Q; Fang Y; Liu Q; Zhang CF; Zhao C; Zhang M; Xu XH
J Ethnopharmacol; 2015 Dec; 175():172-80. PubMed ID: 26385580
[TBL] [Abstract][Full Text] [Related]
63. Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis.
Tong B; Fu L; Hu B; Zhang ZC; Tan ZX; Li SR; Chen YH; Zhang C; Wang H; Xu DX; Zhao H
BMC Pulm Med; 2021 May; 21(1):149. PubMed ID: 33952237
[TBL] [Abstract][Full Text] [Related]
64. 4-OI ameliorates bleomycin-induced pulmonary fibrosis by activating Nrf2 and suppressing macrophage-mediated epithelial-mesenchymal transition.
Wu YX; Zhang YR; Jiang FJ; He S; Zhang YL; Chen D; Tong Y; Nie YJ; Pang QF
Inflamm Res; 2023 Jun; 72(6):1133-1145. PubMed ID: 37169970
[TBL] [Abstract][Full Text] [Related]
65. Alpha-Mangostin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice Partly Through Activating Adenosine 5'-Monophosphate-Activated Protein Kinase.
Li RS; Xu GH; Cao J; Liu B; Xie HF; Ishii Y; Zhang CF
Front Pharmacol; 2019; 10():1305. PubMed ID: 31798444
[No Abstract] [Full Text] [Related]
66. Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo.
Zhang L; Ji YX; Jiang WL; Lv CJ
Braz J Med Biol Res; 2015 Jun; 48(6):545-52. PubMed ID: 25992646
[TBL] [Abstract][Full Text] [Related]
67. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2.
Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X
Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840
[TBL] [Abstract][Full Text] [Related]
68. Geneticin ameliorates pulmonary fibrosis by attenuating the TGF-β/Smad via modulating AMPK/SIRT1 signaling.
Tirunavalli SK; Andugulapati SB
Life Sci; 2024 Jun; 346():122626. PubMed ID: 38614295
[TBL] [Abstract][Full Text] [Related]
69. Arctigenin alleviates TGF-β1-induced epithelial-mesenchymal transition and PAI-1 expression via AMPK/NF-κB pathway in peritoneal mesothelial cells.
Jin G; Su Y; Dong Q; Zhao X; Zhang L; Yan X
Biochem Biophys Res Commun; 2019 Dec; 520(2):413-419. PubMed ID: 31607474
[TBL] [Abstract][Full Text] [Related]
70. FGF21 attenuates pulmonary fibrogenesis through ameliorating oxidative stress in vivo and in vitro.
Zhang S; Yu D; Wang M; Huang T; Wu H; Zhang Y; Zhang T; Wang W; Yin J; Ren G; Li D
Biomed Pharmacother; 2018 Jul; 103():1516-1525. PubMed ID: 29864937
[TBL] [Abstract][Full Text] [Related]
71. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
[TBL] [Abstract][Full Text] [Related]
72. Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo.
Pulivendala G; Bale S; Godugu C
Toxicol Appl Pharmacol; 2020 Mar; 391():114913. PubMed ID: 32032644
[TBL] [Abstract][Full Text] [Related]
73. Angiotensin-Converting Enzyme 2 Inhibits Lipopolysaccharide-Caused Lung Fibrosis via Downregulating the Transforming Growth Factor
Lin X; Lin W; Zhuang Y; Gao F
J Pharmacol Exp Ther; 2022 Jun; 381(3):236-246. PubMed ID: 35347063
[TBL] [Abstract][Full Text] [Related]
74. Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice.
Zhu T; Zhang W; Xiao M; Chen H; Jin H
Int J Mol Sci; 2013 Dec; 14(12):23581-96. PubMed ID: 24300094
[TBL] [Abstract][Full Text] [Related]
75. HIP/PAP protects against bleomycin-induced lung injury and inflammation and subsequent fibrosis in mice.
Zheng X; Li Q; Tian H; Li H; Lv Y; Wang Y; He L; Huo Y; Hao Z
J Cell Mol Med; 2020 Jun; 24(12):6804-6821. PubMed ID: 32352211
[TBL] [Abstract][Full Text] [Related]
76. Modulation of Bleomycin-induced Oxidative Stress and Pulmonary Fibrosis by Ginkgetin in Mice
Ren G; Xu G; Li R; Xie H; Cui Z; Wang L; Zhang C
Curr Mol Pharmacol; 2023; 16(2):217-227. PubMed ID: 35249515
[TBL] [Abstract][Full Text] [Related]
77. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
78. Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation.
Nie Y; Zhang D; Qian F; Wu Y
Int Immunopharmacol; 2019 Sep; 74():105696. PubMed ID: 31229901
[TBL] [Abstract][Full Text] [Related]
79. Nrf2 antioxidant pathway suppresses Numb-mediated epithelial-mesenchymal transition during pulmonary fibrosis.
Zhang Z; Qu J; Zheng C; Zhang P; Zhou W; Cui W; Mo X; Li L; Xu L; Gao J
Cell Death Dis; 2018 Jan; 9(2):83. PubMed ID: 29362432
[TBL] [Abstract][Full Text] [Related]
80. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo.
Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW
Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
